NeurosciencebioRxivPreprint
Evaluating the efficacy of commercially available antisense oligonucleotides to reduce mouse and human tau in vivo
Pranav Vemula, Kathleen M. Schoch, Timothy M. Miller
This study evaluates the efficacy of commercially available antisense oligonucleotides (ASOs) targeting mouse and human tau in vivo, showing reduced tau levels and pathology in mouse models.
DOI 10.1101/2022.12.29.522258